What is NDC 62135-529?

62135-529 is the product NDC for Triamterene And Hydrochlorothiazide, Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 capsule, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Triamterene, Hydrochlorothiazide.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Triamterene And Hydrochlorothiazide?

68 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Triamterene And Hydrochlorothiazide NDC 62135-529

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-529Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0529Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-529-90	6213505299062135052990	90 CAPSULE in 1 BOTTLE (62135-529-90)Marketed from Apr 4, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamterene And Hydrochlorothiazide
Generic name (nonproprietary): triamterene and hydrochlorothiazide
Active ingredients: Triamterene — 37.5 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201407
Marketing start: Dec 9, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Renal K+ Excretion (Physiologic effect)Increased Diuresis (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 62135-529_459f4512-d5e3-a498-e063-6294a90aff39SPL ID 459f4512-d5e3-a498-e063-6294a90aff39SPL set ID 261dd83f-8048-488f-8b71-c4abd9692720RxCUI 198316UNII WS821Z52LQ, 0J48LPH2THUPC 0362135529901
Pharmacologic class: Potassium-sparing Diuretic; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135052990 followed by a unit qualifier and the quantity

Package 62135-0529-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. Triamterene and hydrochlorothiazide capsules are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. Triamterene and hydrochlorothiazide capsules are also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. Triamterene and hydrochlorothiazide capsules may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. Since triamterene and hyd…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-529

What is NDC 62135-529?: 62135-529 is the product NDC for Triamterene And Hydrochlorothiazide, Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 capsule, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Triamterene And Hydrochlorothiazide.
What is the active ingredient?: Triamterene, Hydrochlorothiazide.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Triamterene And Hydrochlorothiazide?: 68 other product NDCs are listed under this name. See all Triamterene And Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Triamterene And Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Triamterene and Hydrochlorothiazide	Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1	TabletOral	REMEDYREPACK INC.	70518-4351	70518-4351-00
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-467	33342-0467-1133342-0467-44
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4270	70518-4270-00
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8700	68788-8700-0168788-8700-0368788-8700-06+1 more
Triamterene and Hydrochlorothiazide	Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8624	68788-8624-0168788-8624-0368788-8624-06+1 more
Triamterene and Hydrochlorothiazide	Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1	TabletOral	Northwind Health Company, LLC	82868-032	82868-0032-3082868-0032-90
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Northwind Health Company, LLC	82868-022	82868-0022-30
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Northwind Health Company, LLC	82868-006	82868-0006-3082868-0006-90
Triamterene and Hydrochlorothiazide	Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1	TabletOral	Northwind Health Company, LLC	51655-582	51655-0582-2651655-0582-52
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	St. Mary's Medical Park Pharmacy	60760-783	60760-0783-90

All 69 Triamterene And Hydrochlorothiazide NDCs

Other NDCs under ANDA 201407

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201407
Product	Strength	Form · route	Labeler	Product NDC
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	A-S Medication Solutions	50090-2028
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Proficient Rx LP	63187-905
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0504
Triamterene and Hydrochlorothiazide	Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-1084